Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer
Explore this paper's citation graph
Summary
This review aims to provide an overview of several types of receptors overexpressed in lung cancer and focused therapeutic involvement of nanosized carriers as targeting/developing tools for the treatment of lung cancer.
- Type
- article
- Published
- 2020-12-01
- Cited by
- 23
- References
- 325
- OpenAlex
- https://openalex.org/W3084708604
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:225203631
Keywords
Nanocarriers, Drug delivery, Lung cancer, Medicine, Targeted drug delivery
References
- pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles.
- Cancer active targeting by nanoparticles: a comprehensive review of literature
- Management of EGFR mutated nonsmall cell lung carcinoma patients
- In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
- Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
- Melatonin and non-small cell lung cancer: new insights into signaling pathways
- Protein- and Peptide-drug conjugates: an emerging drug delivery technology.
- Drug delivery in oncology : from basic research to cancer therapy
- Nanotechnology approaches for inhalation treatment of lung diseases.
- Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention
- Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
- Polypeptide/doxorubicin hydrochloride polymersomes prepared through organic solvent-free technique as a smart drug delivery platform.
- Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
- Adenosine Receptors and Cancer
- Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles.
- A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer
- Nanocarriers for cancer-targeted drug delivery
- Polymersome-based drug-delivery strategies for cancer therapeutics
- Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
- Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer
Cited by
- Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review
- A comprehensive review on natural bioactive films with controlled release characteristics and their applications in foods and pharmaceuticals
- Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy
- Edible coating as postharvest management strategy for shelf-life extension of fresh tomato (Solanum lycopersicum L.): An overview.
- Afatinib liposomal dry powder inhaler: Targeted pulmonary delivery of EGFR inhibitor for the management of lung cancer
- Doxorubicin-Loaded Extracellular Vesicles Enhance Tumor Cell Death in Retinoblastoma
- Research advances of in vivo biological fate of food bioactives delivered by colloidal systems
- LIPOSOMAL DRY POWDER INHALER: NOVEL PULMONARY TARGETED DRUG DELIVERY SYSTEM FOR THE TREATMENT OF LUNG CANCER
- DOE supported optimization of biodegradable polymeric nanoparticles based dry powder inhaler for targeted delivery of afatinib in non-small cell lung cancer
- Advances and challenges in the treatment of lung cancer.
- Recent advances and prospects in naringin nanocarrier drug delivery system for cancer management
- Assessment of nanocarrier mediated afatinib pharmacokinetic: A comparative in-vivo study in rat model for enhanced therapeutic efficacy in lung cancer management
- Membrane Permeability and Drug Targeting Potential of Phospholipid‐Based Nanocarriers in Lung Cancer Therapy
- Crafting a Molecular Trojan Horse: Sialic Acid-Modified PLGA Nanoparticles for Targeted Lung Cancer Therapy.
- Modified-Release Pulmonary Delivery Systems for Labile Bioactives: Design, Development, and Applications
- Metabolism-targeted therapy in NSCLC - A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24).
- Inhibitors as a therapeutic frontier in lung cancer: Mechanism, opportunities, and molecular docking studies
- PEGylated dendrimers for precision cancer therapy: Advances in tumor targeting, drug delivery, and clinical translation.
- CD44 targeted functionalized nanocarriers for non-small cell lung cancer
- Nanomedicines: Applications and Toxicological Concerns
Related papers
- Development of targeted micelles and polymersomes prepared from degradable RAFT-based diblock copolymers and their potential role as nanocarriers for chemotherapeutics
- Ligand decorated biodegradable nanomedicine in the treatment of cancer.
- Asymmetrical Polymer Vesicles for Drug delivery and Other Applications
- Nanoparticle-mediated Drug Delivery Systems (DDS) in the Central Nervous System
- Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery.
- Targeted Drug Delivery
- An effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systems.